【レポートの概要（一部）】
Table of Contents
Chapter 1. Executive Summary
1.1. Antidiabetics– Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Antidiabetics Industry Outlook
2.1. Market Segmentation
2.2. Market size and growth prospects
2.3. Antidiabetics – Market dynamics
2.3.1. Market driver analysis
2.3.1.1 Growing prevalence of diabetes
2.3.1.2 Presence of a strong product pipeline portfolio
2.3.1.3 Growing prevalence of lifestyle induced disorders such as obesity
2.3.2. Market Restraint Analysis
2.3.2.1. High insulin prices
2.4. Key Opportunities Prioritized
2.5. Industry Analysis – Porter’s
2.6. Antidiabetics – PESTEL analysis
2.7. Antidiabetics market – Pipeline overview
Chapter 3. Antidiabetics Product Outlook
3.1. Antidiabetics market share by product, 2013 & 2020
3.2. Insulin
3.2.1. Insulin market share, by product, 2013 & 2020
3.2.2. Rapid acting analog market
3.2.2.1. Rapid acting analog market, 2012 – 2020 (USD Million)
3.2.3. Long acting analog market
3.2.3.1 Long acting analog market, 2012 – 2020 (USD Million)
3.2.4. Premixed analog market
3.2.4.1 Premixed analog market, 2012 – 2020 (USD Million)
3.2.5. Premixed insulin market
3.2.5.1. Premixed insulin market, 2012 – 2020 (USD Million)
3.2.6. Short acting insulin market
3.2.6.1. Short acting insulin market, 2012 – 2020 (USD Million)
3.2.7. Intermediate acting insulin market
3.2.7.1 Intermediate acting insulin market, 2012 – 2020 (USD Million)
3.3. Other antidiabetics
3.4. Alpha glucosidase inhibitors
3.4.1. Alpha glucosidase inhibitors market, 2012 – 2020 (USD Million)
3.5. Biguanides
3.5.1. Biguanides market, 2012 – 2020 (USD Million)
3.6. Sulphonylureas
3.6.1. Sulphonylureas market, 2012 – 2020 (USD Million)
3.7. GLP 1 (Glucagon like peptide) agonists
3.7.1. GLP 1 agonist market, 2012 – 2020 (USD Million)
3.8. DPP – 4 (Dipeptyl peptides) inhibitors
3.8.1. DPP-4 market, 2012 – 2020 (USD Million)
3.9. Meglitinides
3.9.1. Meglitinides market, 2012 – 2020 (USD Million)
3.10. SGLT – 2 (sodium glucose transport proteins) inhibitors
3.10.1. SGLT – 2 inhibitors market, 2012 – 2020 (USD Million)
3.11. Thiazolodinediones
3.11.1. Thiazolodinediones market, 2012 – 2020 (USD Million)
Chapter 4. Antidiabetics Regional Outlook
4.1. Antidiabetics market share, by region, 2013 & 2020
4.2. North America antidiabetics market
4.2.1. North America antidiabetics market, 2012 – 2020 (USD Million)
4.3. Europe antidiabetics market
4.3.1. Europe antidiabetics market, 2012 – 2020 (USD Million)
4.4. Asia Pacific antidiabetics market
4.4.1. Asia Pacific antidiabetics Market, 2012 – 2020 (USD Million)
4.5. RoW antidiabetics market
4.5.1. RoW antidiabetics market, 2012 – 2020 (USD Million)
Chapter 5. Competitive Landscape
5.1 Sanofi Aventis
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Takeda Pharmaceuticals
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Eli Lilly
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Oramed Pharmaceuticals Inc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Merck & Co. Inc.
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Novo Nordisk
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Bristol-Myers Squibb
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Halozyme Therapeutics
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Pfizer
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumptions
6.3. List of Data Sources
List of Tables
1. Antidiabetics – Industry Summary & Critical Success Factors (CSFs)
2. Global insulin market, by product, 2012 – 2020 (USD Million)
3. Global other antidiabetics market, by product, 2012 – 2020 (USD Million)
4. Global antidiabetics market, by region, 2012 – 2020 (USD Million)
5. Antidiabetics – Key market driver analysis
6. North America diabetes prevalence (national prevalence %), 2013 & 2035
7. Europe diabetes prevalence (national prevalence %), 2013 & 2035
8. Latin America diabetes prevalence (national prevalence %), 2013 & 2035
9. MENA and Africa diabetes prevalence (national prevalence %), 2013 & 2035
10. CIS diabetes prevalence (national prevalence %), 2013 & 2035
11. Asia Pacific diabetes prevalence (national prevalence %), 2013 & 2035
12. Antidiabetics – Key market restraint analysis
13. Antidiabetics market – Pipeline overview
14. Insulin types and brands
15. List of brands of alpha glucosidase for diabetes
16. List of major brands of biguanides for diabetes
17. Brands and generic names of sulphonylureas for diabetes
18. Brands and generic names of GLP-1 for diabetes
19. List of major brands of DPP-4 for diabetes
20. List of major drugs of meglitinides for diabetes
21. List of major drugs of SGLT-2 for diabetes
22. North America insulin market, by product, 2012 – 2020 (USD Million)
23. North America insulin market, by application, 2012 – 2020 (USD Million)
24. North America other antidiabetics market, by product, 2012 – 2020 (USD Million)
25. Europe insulin market, by product, 2012 – 2020 (USD Million)
26. Europe insulin market, by application, 2012 – 2020 (USD Million)
27. Europe other antidiabetics market, by product, 2012 – 2020 (USD Million)
28. Asia Pacific insulin market, by product, 2012 – 2020 (USD Million)
29. Asia Pacific insulin market, by application, 2012 – 2020 (USD Million)
30. Asia pacific other antidiabetics market, by product, 2012 – 2020 (USD Million)
31. RoW insulin market, by product, 2012 – 2020 (USD Million)
32. RoW insulin market, by application, 2012 – 2020 (USD Million)
33. RoW other antidiabetics market, by product, 2012 – 2020 (USD Million)
List of Figures
1. Antidiabetics market segmentation
2. Global antidiabetics market revenue, 2012 – 2020 (USD Million)
3. Antidiabetics: Market dynamics
4. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
5. Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
6. Key opportunities prioritized
7. Antidiabetics market – Porter’s analysis
8. Antidiabetics market – PESTEL analysis
9. Antidiabetics market share by product, 2013 & 2020
10. Insulin market share by product, 2013 & 2020
11. Rapid acting analog market, 2012 – 2020 (USD Million)
12. Long acting analog market, 2012 – 2020 (USD Million)
13. Premixed analog market, 2012 – 2020 (USD Million)
14. Premixed insulin market, 2012 – 2020 (USD Million)
15. Short acting insulin market, 2012 – 2020 (USD Million)
16. Intermediate acting insulin market, 2012 – 2020 (USD Million)
17. Global alpha glucosidase inhibitors market, 2012 – 2020 (USD Million)
18. Global biguanides market, 2012 – 2020 (USD Million)
19. Global sulphonylureas market, 2012 – 2020 (USD Million)
20. Global GLP 1 agonist market, 2012 – 2020 (USD Million)
21. Global DPP-4 market, 2012 – 2020 (USD Million)
22. Global meglitinides market, 2012 – 2020 (USD Million)
23. Global SGLT – 2 inhibitors market, 2012 – 2020 (USD Million)
24. Global thiazolodinediones market, 2012 – 2020 (USD Million)
25. Antidiabetics market share by region, 2013 & 2020
26. North America antidiabetics market, 2012 – 2020 (USD Million)
27. Europe antidiabetics market, 2012 – 2020 (USD Million)
28. Asia Pacific antidiabetics market, 2012 – 2020 (USD Million)
29. RoW antidiabetics market, 2012 – 2020 (USD Million)
【レポート販売概要】
■ タイトル：抗糖尿病薬の世界市場分析：製品別（インスリン、ビグアニド、チアゾロジンジオン、GLP-アゴニスト、スルホニル尿素、DPP-4阻害剤、SGLT-2、アルファ – グルコシダーゼ阻害剤、メグリチニド）、セグメント予測 -2020■ 英文：Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020
■ 発行日：2015年1月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707051
■ 調査対象地域：グローバル
- ルーマニアの風力発電市場2016：発電能力、生産、投資動向、制度、企業Wind Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Wind Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry ana …
- 世界主要国のカンピロバクター検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals &nbs …
- アメリカ教育産業における人口知能（AI）市場2017-2021About Artificial Intelligence Artificial intelligence analyzes huge data sets at granular levels. These data can potentially help both students and mentors who are involved in the developmental and personalized education process. Irrespective of the subject, these solutions have capabilities to create personalized learning profiles for students. The technology helps educators to develop optimized …
- 原子力業界のM&A及び投資動向2012Nuclear Energy Annual Deals Analysis: M&A and Investments Trends - 2012 Summary GlobalData’s “Nuclear Energy Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on the mergers and acquisitions (M&A) and financings in the alternative energy market. The report provides detailed information on mergers and acquisitions (M&A), equity/debt o …
- スマートホームセキュリティの世界市場展望2017-20276According to Stratistics MRC, the Global Smart Home Security Market is accounted for $618.63 million in 2017 and is expected to reach $3,223.20 million by 2026 growing at a CAGR of 20.1% during the forecast period. Evolving consumer safety and security preferences, up surge in the penetration of connected homes, and growing high net worth population of market players across the globe are the major …
- 世界の塩素化ポリ塩化ビニル市場2015The Global Chlorinated Polyvinyl Chloride Industry Report 2015 is a professional and in-depth study on the current state of the CPVC industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The CPVC market analysis is provided for the international markets including development trends, competitive landscape an …
- 経皮吸収パッチの世界市場及びパイプラインインサイトTechnological progress is continuously increasing allowing pharmaceutical companies to develop newer products with higher pharmacological benefits. Transdermal patches are extension of their continuous efforts due to which several patients have been able to improve quality of life. This market segment has yet to be tapped as only few disease indications are being covered under their treatment. Pha …
- 世界のパワートランジスタ（Power Transistor）市場動向（2012-2016）TechNavio's analysts forecast the Global Power Transistor market to grow at a CAGR of 7.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for power efficient electronic products. The Global Power Transistor market has also been witnessing the convergence of different technologies on a single platform. However, slowdown in the g …
- インドの発電機市場2016-2020About the Genset Market in India Electricity is one of the major requirements for industrial, commercial, infrastructural, and residential growth of any country. The availability of uninterrupted power supply is necessary to fuel the growth of every industry, be it large-scale or small-scale, education, manufacturing, or healthcare. Low fuel availability of electricity is one of the major concerns …
- 2014年戦略提言：Echovirusの診断検査市場The report presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 関節鏡の世界市場2017-2021About Arthroscopy DevicesAn arthroscopy is a minimally invasive surgical procedure used to visualize and diagnose problems in the joint through an arthroscope. Arthroscope has a small lens and the fiber optic light of the device is connected to a camera and monitor, which helps the surgeon to observe and perform surgery. This technique is carried out in the joints of knees, shoulders, hips, elbows …
- カンナビス（大麻）検査の世界市場：製品・ソフトウェア別（LC、GC、分光器、カラム、標準、付属品、LIMS）、サービス別（ポテンシー、殺虫剤、重金属、遺伝子検査）、エンドユーザー別（ラボ、製薬、研究）、地域別予測Global Canabbis testing Market valued approximately USD 822.0 million in 2016 is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2017-2025. Key factors which gives growth to the Canabbis testing market are legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories (specifically in the U.S.); growing adoption of LIMS …
- 非血管ステントの世界市場：胃腸用ステント、泌尿器科用ステント、肺用ステントAbout Non-vascular Stents A non-vascular stent is a tube shaped like a blood vessel that is used to open a passage between two hollow spaces in the body. This type of stent is an implantable device made up of materials such as ninitol, cobalt-chromium alloys, and silicone. The stents are designed to maintain the patency of stenotic vessels. Non-vascular stents are used to make a pathway in the bod …
- 血液検査・フローサイトメトリーの世界市場The report identifies the major opportunities for hematology and flow cytometry instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers.Contains 23 pages
- Opioid-Induced Constipation：市場分析及び予測（～2017）OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2017 Summary The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated by OTC laxatives set to undergo substantial growth between 2012 and 2017. The main drivers of growth will be an increase in the diagnosed OIC population. This is fuelled by a relaxation of regulation …
